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Introduction
Waldenström’s  macroglobulinemia  (WM)  is  a  low-grade  lym-
phoma  originally  described  in  1944.1 It  is  a  malignant
lymphoproliferative  disease  characterized  by  the  clonal
expansion  of  B  cells  with  lymphoplasmacytic  differentiation
that  secrete  monoclonal  immunoglobulin  M  (IgM).  Diagnos-
tic  criteria  are  based  on  speciﬁc  clinical,  morphological,
and  immunophenotypic  parameters,  besides  the  evidence
of  pathologic  plasmacytoid  cells  in  the  bone  marrow.  Symp-
toms  can  be  related  either  to  tumor  inﬁltration  or  to  the
amount  and  properties  of  the  circulating  monoclonal  pro-
tein:  cardiac  and  renal  failure,  mucosal  bleeding,  headache,
visual  disturbances,  ataxia,  and  eventually  coma  have  been
described  as  part  of  the  clinical  spectrum  of  WM.  Periph-
eral  neuropathy  occurs  in  nearly  half  of  the  patients  and
is  mostly  related  to  the  reactivity  of  the  IgM  protein  with
different  neural  antigens.  Frequently,  it  represents  the  ini-
tial  presentation  of  the  disease;  sometimes  it  could  precede
the  diagnosis  of  macroglobulinemia  by  several  years.2
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reserved.onversely,  the  onset  of  audio-vestibular  symptoms  and
igns  as  a presenting  phenomena  of  WM  is  unusual.  This
eport  presents  an  original  case,  the  ﬁrst  ever  disclosed  in
iterature,  of  bilateral  vestibular  loss  (BVL)  as  the  presenting
ymptom  of  WM,  and  the  relevant  literature  is  reviewed.
ase report
 57-year-old  woman  presented  at  the  hospital  with  the
nset  of  asthenia,  fatigue,  progressive  dizziness,  and  dis-
quilibrium  for  a  few  months.  Immediately  before  the
ymptoms  began,  she  had  already  experienced  positional
ertigo  spells  while  laying  down  or  getting  up  from  bed.
ight  posterior  canal  benign  paroxysmal  positional  vertigo
as  diagnosed  and  treated  successfully  with  two  cycles
f  repositioning  maneuvers  at  another  institution.  Since
hen,  she  had  started  to  feel  progressively  unsteady,  light-
eaded,  and  even  experienced  oscillopsia  while  walking,
ecoming  severely  disabled  during  her  daily  activities.  She
lso  noticed  a  rapidly  progressive  bilateral  hearing  impair-
ent  and  recurrent  nasal  bleedings.  Surprisingly,  she  did
ot  show  any  spontaneous  or  positional  nystagmus  at  the
nfrared  video-oculography,  while  audiometric  test  revealedal  hearing  loss  (Fig.  1a).  Subsequently,  she  was  submitted
o  an  extensive  neuro-otologic  assessment:  standard  bither-
al  caloric  test  showed  minimal/absent  caloric  responses
rgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
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eigure  1  Pure-tone  audiometric  test  showing  moderate-severe
ymmetrical  involvement,  before  (a)  and  after  therapy  (b).
ilaterally.  No  response  was  elicited  even  after  ice-water
timulation,  proving  bilateral  deﬁcient  vestibulo-ocular
eﬂex  (VOR)  at  low-frequency  range.  High-frequency  VOR
ain  for  all  six  semicircular  canals  was  tested  with  the
ideo  head  impulse  test  (vHIT).  VOR  gain  for  each  canal
howed  to  be  extremely  deﬁcient  (Fig.  2).  Saccular  and
tricular  function  was  measured  using  air-conducted  cer-
ical  vestibular  evoked  myogenic  potentials  (VEMPs)  and
one-conducted  ocular  VEMPs,  respectively.  No  reliable
esponse  could  be  detected  bilaterally  (Fig.  3).  Tempo-
al  bone  high-resolution  computed  tomography  (CT)  scan
as  negative  and  gadolinium-enhanced  brain  magnetic  res-
nance  imaging  (MRI)  excluded  central  nervous  system
CNS)  involvements.  All  principal  causes  of  bilateral  vesti-
ular  failure  were  excluded  through  an  accurate  anamnesis.
he  patient  was  submitted  to  a  parallel  internal  medicine
ssessment,  which  detected  signs  of  pulmonary  arterial
ypertension.  Peripheral  blood  analysis  revealed  pancy-
openia  (WBC  2.78  ×  109/L,  RBC  3.32  ×  1012/L,  Hemoglobin
6  g/L,  HCT  30.1%,  Platelets  94  ×  109/L).  Thus,  she  was
ubmitted  to  the  Hematologic  Unit  of  the  institution  for  fur-
her  investigation.  Serum  protein  electrophoresis  revealed
t
h
p
lteral  sensorineural  hearing  loss  for  high  frequencies  with  nearly
ypergammaglobulinemia  with  a  homogeneous  narrow  and
ense  band  migrating  to  the  gamma  region  (Fig.  4),  with
n  albumin/globulins  ratio  of  0.44.  Quantitative  testing
or  immunoglobulins  showed  abnormal  serum  levels  of  IgM
araprotein  (92.71  g/L)  and  serum  immunoﬁxation  resulted
ositive  for  monoclonal  component  type  IgM/kappa.  Urine
mmunoﬁxation  test  was  positive  for  Bence  Jones  pro-
ein.  She  immediately  underwent  a bone  marrow  biopsy
hat  demonstrated  diffuse  monoclonal  lymphoplasmacytic
nﬁltrate  (IgM+,  IgD-,  CD20+,  CD3-immunophenotype  with
on-paratrabecular  pattern  of  inﬁltration  and  15%  resid-
al  bone  marrow  cellularity),  conﬁrming  the  diagnosis  of
M.  Residual  physical  examination  proved  substantially
ormal  (including  the  lack  of  lymphadenopathies,  pur-
ura,  and  sensorimotor  neuropathy)  besides  acrocyanosis
nd  papilledema.  To  complete  the  diagnostic  workup,  the
atient  was  then  submitted  to  a  total  body  CT  scan  that
xcluded  organomegalies  or  lytic  bone  lesions.  She  was
herefore  scheduled  for  a combination  therapy  based  on
igh-dose  intravenous  steroids  and  plasmapheresis.  The
atient  was  re-evaluated  at  the  institution  two  months
ater,  presenting  with  a  partial  normalization  of  blood  cells
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Figure  2  Video  head  impulse  test  (vHIT)  with  an  ICS  Video-oculographic  system  (GN  Otometrics  A/S  --  Denmark)  for  all  semicircular
canals (LH:  left  horizontal,  RH:  right  horizontal,  LA:  left  anterior,  RP:  right  posterior,  LP:  left  posterior,  RA:  right  anterior).  Passive,
unpredictable 5◦--20◦,  50◦--250◦/s,  and  750◦--5000◦/s2 head  impulses  were  delivered  manually  on  the  plane  of  the  horizontal  and
vertical canals  while  the  patient  was  asked  to  keep  looking  at  an  earth-ﬁxed  target.  On  the  right,  blue  lines  represent  head  impulses
exciting left  canals,  red  lines  correspond  to  head  impulses  exciting  right  canals,  and  green  lines  represent  eye  movements  induced
by the  activation  of  the  vestibulo-ocular  reﬂex  (VOR)  following  each  head  impulse.  For  each  canal,  the  corresponding  mean  value  of
VOR gains  with  related  standard  deviation  ()  is  reported.  Overt  saccades  can  be  easily  detected.  On  the  left,  each  dot  represents
R  sho
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pthe VOR  gain  (eye  velocity/head  velocity)  for  each  impulse.  VO
analysis  (WBC  4.45  ×  109/L,  RBC  3.66  ×  1012/L,  Hemoglobin
104  g/L,  HCT  33.1%,  Platelets  114  ×  109/L,  IgM  32.5  g/L,
albumin/globulins  ratio  of  1.42).  She  felt  relieved  from
fatigue  and  asthenia,  and  her  audiometric  test  surprisingly
showed  a  consistent  improvement  in  high-frequency  hearing
thresholds  bilaterally  (Fig.  1b).  Nevertheless,  a  further  oto-
neurologic  assessment  conﬁrmed  a  persistent  deﬁciency  in
her  vestibular  function.Discussion
BVL  is  a  rare  condition.  Though  its  etiology  often
remains  unknown,  as  in  most  studies  the  idiopathic  form
c
s
r
rwed  to  be  extremely  deﬁcient  for  all  canals.
oincides  with  the  largest  group  of  patients,3,4 this  disor-
er  is  thought  to  represent  the  ﬁnal  common  expression  of
ifferent  pathologic  conditions,  including  ototoxicity,  bilat-
ral  endolymphatic  hydrops,  infections,  tumors  (cerebellar
umors,  neuroﬁbromatosis  type  2),  surgical  procedures  on
he  inner  ear  or  on  the  VIII  cranial  nerves,  and  autoimmune
isease.3,4 BLV  typically  manifests  with  chronic  disequili-
rium,  gait  ataxia,  and  oscillopsia  while  walking.  Only  a
ew  case  series  and  literature  reviews  report  hematologic
athologies  as  a  possible  cause  of  BVL3,4 and,  similarly,
ochleo-vestibular  symptoms  appear  to  be  an  unusual  pre-
entation  of  hematological  disorders.5 Nevertheless,  several
eports  described  audio-vestibular  manifestations  occur-
ing  in  patients  with  WM.  A  direction-changing  positional
574  Castellucci  A  et  al.
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Figure  3  Vestibular  evoked  myogenic  potentials  (VEMPs)  evaluated  using  an  Epic  Plus  system  (Labat  s.r.l.  --  Mestre,  Italy)  with  a
two-channel averaging  capacity.  (a)  Air  conducted  (AC)  cervical  VEMPs  were  evoked  delivering  tone  burst  (TB)  via  headphones  with
frequency 500  Hz,  duration  8  ms,  intensity  120  dB  SPL,  and  stimulation  rate  5  Hz.  Upper  blue  lines  correspond  to  myogenic  responses
recorded on  the  left  sternocleidomastoid  muscle  (SCM),  lower  red  lines  represent  responses  recorded  on  the  right  SCM.  (b)  Bone
conducted (BC)  ocular  VEMPs  were  assessed  using  three  different  sagittal  (Fz)  stimulations:  TB  250  Hz  (duration  8  ms,  intensity
1.5 V),  TB  500  Hz  (8  ms,  1.5  V),  and  click  (0.5  ms,  1.0  V),  all  delivered  by  a  hand-held  minishaker  with  an  attached  Perspex  rod  (type
4810 -- Bruel  and  Kjaer  P/L,  Denmark),  with  intensity  ampliﬁcation  modiﬁed  through  a  power  ampliﬁer  (type  2718  --  Bruel  and
Kjaer). Blue  lines  represent  responses  recoded  under  patient’s  left  e
eye. No  reliable  potentials  could  be  detected  at  the  SCM  nor  under  
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lack  of  responses  after  stimulation  of  all  canals  and  mac-igure  4  Serum  electrophoresis  showing  a  homogeneous  nar-
ow peak  and  a  dense  band  in  the  gamma  region.
ystagmus  has  been  explained  through  the  effect  of  heavy
lobulins  on  the  cupulae  of  the  canals,  resulting  in  a  buoy-
ncy  mechanism.6 Conversely,  hearing  loss  and  various  levels
f  vestibular  impairment  have  been  related  to  different
athologic  processes  occurring  in  WM,  such  as  multiple  hem-
rrhagic  phenomena,7 small  vessel  thrombosis  secondary  to
udden  release  of  clotting  factors,5 and  increased  blood
iscosity  resulting  in  the  obstruction  of  labyrinthine  small
essels.8 Moreover,  some  reports  have  also  described  a
ymptomatic  improvement  with  a  reduction  of  blood  hyper-
iscosity,  mainly  after  plasmapheresis.5,6 Indeed,  one  of  the
ost  important  consequences  related  to  the  rheological
roperties  of  circulating  IgM  pentameters  is  hyperviscosity
yndrome  (HS),  which  is  a  distinguishing  feature  of  WM.
u
e
dye;  red  lines  correspond  to  responses  recorded  under  the  right
the  eyes,  besides  uncertain  late  responses  after  click  stimuli.
evertheless,  it  is  observed  in  only  10%--30%  of  patients  with
M  and  it  can  be  also  seen  in  patients  with  other  hemato-
ogical  disorders.9 It  is  the  consequence  of  the  abnormal
ize  and  increased  blood  concentration  of  the  monoclonal
rotein,  leading  to  an  aggregation  of  red  cells  and  an
ncreased  vascular  resistance.  This  condition  is  responsible
or  the  onset  of  typical  symptoms,  such  as  skin  and  mucosal
leeding,  visual  disturbance,  a huge  variety  of  neurological
isorders,  and  cardiovascular  manifestations.1,9 Once  diag-
osed,  it  must  be  treated,  as  it  may  lead  to  life-threatening
onsequences.  The  reason  why  particular  organ  sites,  such
s  the  eyes  and  the  CNS,  are  more  frequently  involved  than
thers  in  HS  may  be  explained  by  the  sluggish  ﬂow  occurring
n  certain  vascular  beds,  resulting  in  further  enhancement
f  blood  viscosity.  Moreover,  it  is  well  known  that  the  inner
ar  and  the  retina  are  similar  in  terms  of  vascularization,
onsidering  their  peripheral  location  and  their  blood  supply
f  terminal  type.  Therefore,  it  could  be  easily  hypothe-
ized  that  the  same  typical  pathologic  ﬁndings  documented
n  the  retina  of  patients  with  HS  can  likely  occur  in  the
abyrinth  of  the  same  subjects.8 On  the  basis  of  the  abnor-
al  level  of  serum  IgM  and  the  typical  symptoms  of  HS,  it
s  believed  that  the  BVL  detected  in  the  present  case  could
e  likely  explained  on  a  vascular  basis.  In  particular,  serum
yperviscosity  could  have  been  responsible  for  obstruction
f  capillaries,  resulting  in  anoxia  of  the  peripheral  vesti-
ular  end  organ  as  demonstrated  by  the  nearly  absolutelae.  Even  the  positional  vertigo  spells  that  occurred  in  the
arly  stage  of  the  disease  could  be  explained  by  a  sudden
eﬁcit  of  utricular  perfusion.  Detachment  of  otoliths  due
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to  an  ischemic  lesion  of  the  utricular  macula  could  have
resulted  in  canalolithiasis  of  the  still  functionally  active  pos-
terior  canal.  It  could  have  represented  the  ﬁrst  premonitory
sign  of  an  incipient  progressive  vestibular  anoxia,  reinforcing
the  hypothesis  of  hyperviscosity  as  the  basis  of  vestibular
loss.
In  contrast  with  most  of  the  literature  in  which  hear-
ing  loss  usually  prevails  on  vestibular  symptoms  in  patients
affected  by  WM,5,7 in  the  present  case  cochlear  function
was  partially  spared  by  hypoxia,  with  only  a  bilateral  high-
frequency  hearing  impairment.
Besides  subjective  anatomo-physiologic  factors  privileg-
ing  cochlear  versus  vestibular  microcirculation,  the  reason
why  mainly  vestibular  receptors  have  been  affected  by
ischemia,  with  only  a  partial  involvement  of  the  basal  turn
of  the  cochlea,  could  be  explained  considering  the  anatomy
of  vascular  inner  ear  supply.  On  the  basis  of  scanning  elec-
tron  microscopic  studies,  a  model  for  the  vascular  pathways
in  the  labyrinth  has  been  described,  and  therefore  different
clinical  scenarios  have  been  proposed  depending  on  which
arterial  or  venous  branch  could  be  involved  by  ischemia.10
According  to  this  model,  selective  combined  ischemia  at
the  level  of  both  vestibular  anterior  artery  (supplying  lat-
eral  and  superior  canal  ampullae  and  utricular  macula)  and
vestibulo-cochlear  artery  (feeding  posterior  canal  ampulla,
saccular  macula,  and  cochlear  basal  turn)  may  represent  the
pathologic  event  responsible  for  the  onset  of  the  present
symptoms,  sparing  vascular  supply  to  the  upper  part  of  the
cochlea.  Similarly,  blood  stagnation  at  the  level  of  the  audi-
tory  internal  vein  in  association  with  a  blockage  of  the
venous  drainage  from  the  lower  part  of  the  cochlea  could
result  in  the  same  clinical  picture.
Finally,  even  more  particular  combinations  among  insuf-
ﬁcient  arterial  ﬂows  and  speciﬁc  interruptions  of  the  venous
return  could  lead  to  anoxia  of  the  same  labyrinthine  com-
partments  and  therefore  to  damage  of  the  same  receptors.
Conclusion
In  patients  with  a  clinical  picture  consistent  with  BVL,  even
without  evident  systemic  involvement,  hematological  disor-
ders  such  as  WM  should  always  be  considered  as  underlying
causative  factors.  It  is  important  for  neuro-otologists  to
consider  HS  in  differential  diagnosis  of  cochleo-vestibular
1ibular  loss  575
ymptoms  and  signs,  as  it  could  lead  even  to  life-threatening
onsequences.  Similarly,  hematologists  should  be  aware  of
he  possibly  of  irreversible  damages  on  sensorineural  end
rgans,  such  as  the  inner  ear,  caused  by  the  extremely  high
evels  of  IgM  and  HS.  In  fact,  thanks  to  its  particularly  high
ensitivity,  the  inner  ear  could  be  an  early  detector  of  sys-
emic  pathological  manifestations  as  shown  in  this  unique
ase  report.  Moreover,  subclinical  alterations  of  cochleo-
estibular  function  could  occur  more  frequently  in  patients
ith  WM.  Therefore,  a  systematic  neuro-otologic  assess-
ent  should  be  promptly  suggested  in  such  cases,  in  order  to
revent  labyrinthine  hypoxia  and  eventually  to  adopt  appro-
riate  therapeutic  strategies.
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